The IPO Buzz: Anbio Biotechnology Prices IPO at $5.00 – Low End
Anbio Biotechnology (NNNN) priced its IPO at $5.00 – the low end of its $5.00-to-$6.00 price range – and sold all 1.6 million Class A ordinary shares – the number in the prospectus – to raise $8.0 million on Tuesday night, Feb. 18, 2025. Shares of Anbio Biotechnology (NNNN) opened at $5.26 - up 26 cents from their IPO price - on NASDAQ at 11:35 a.m. EST today - Wednesday, Feb. 19, 2025 - o..
Read more February 19, 2025IPO Calendar
Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
---|---|---|---|---|---|---|
Aardvark Therapeutics | AARD | 5.9 | $ 94.2 mil | 2/13/2025 Priced | S/O | S/O |
Artius II Acquisition Corp. | AACBU | 20.0 | $ 200.0 mil | 2/13/2025 Priced | S/O | S/O |
Karman Holdings (TCFIII SPACECO HOLDINGS LLC) | KRMN | 23.0 | $ 506.0 mil | 2/13/2025 Priced | S/O | S/O |
Last 100 IPOs - February 19, 2025
Number of IPOs priced : | 100 |
Number Up: | 42 |
Number Down: | 49 |
Number Unchanged: | 9 |
Percentage Change From Issue Price: | -12.13% |
Percentage Change for The Nasdaq Composite | 9.11% |
2025 IPO Scorecard - February 19, 2025
Number of IPOs priced (Excluding 57 units) : | 180 |
Number Up: | 72 |
Number Down: | 101 |
Number Unchanged: | 7 |
Total Return From Issue Price: | 8.14% |
The Nasdaq Composite Index YTD % Change | 35.22% |